Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
CYPA US Equity
Cyphaira Corp.
1.22USD
Healthcare
Drug Manufacturers - Specialty & Generic
96)Comparar97)Tesis →
Market Cap
$39M
Shares Outstanding
32M
— Annual —FY2021
Current Ratio
0.07
Book Value / Share
0
CYPA US Equity
1.22USD
Tesis →

Cyphaira Corp. (CYPA): análisis fundamental y valoración

Cyphaira Corp. cotiza a 1.22 USD y tiene una capitalización bursátil de $39M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaOTCPaísUnited StatesBeta0.56Web↗ www.growthstalk.com

Cyphaira Corp. designs and develops a technology platform with AI-native decision intelligence. The company provides SolvixLMS, an AI-based cannabis solventless extraction software product. It also engages in the sowing of seeds for cultivation and the selling of cannabis. The company was formerly known as Growth Stalk…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
—
P/Sales
—
P/Book
342.5×
Rentabilidad (Último Anual)
Gross Margin
—
Operating Margin
—
Net Margin
—
FCF Margin
—
ROE
—
ROCE
—
ROA
—
Effective Tax Rate
—
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
0.07
Interest Coverage
—
Working Capital
−$810,810
Book Value / Share
0
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
—
Net Income YoY
—
FCF YoY
—
EPS Diluted YoY
—
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
—
CapEx % Revenue
—
Rev / Employee
—
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaCYPAMediana SectorΔ
Gross Margin—57.0%—
Operating Margin—-38.6%—
Net Margin—-33.6%—
FCF Margin—-13.9%—
ROE—-40.4%—
ROA—-32.0%—
Current Ratio0.072.84-2.77
Debt / Equity—0.28—
Scoring Fundamental
Capital Allocation
0/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✗DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✗Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)